News
AI tool reveals MS drug interactions, offers safer options
- Author:
- Liam Davenport
Deep learning–based methods are “useful” in screening for potential interactions both between drugs and with foods.
News
Ocrelizumab benefit confirmed in older patients with MS
- Author:
- Liam Davenport
Lower rates of relapse were seen in older patients taking ocrelizumab, but the risk for relapse in this age group is low.
News
Confirmed: Intermittent use of benzodiazepines is the safest option
- Author:
- Liam Davenport
“We’ve always known that there was a problem, but there haven’t been high-quality epidemiological studies like this that allowed us to say what...
News
Esketamine bests quetiapine for severe depression in head-to-head trial
- Author:
- Liam Davenport
“These patients are not resistant, they just have resistance to monoaminergic drugs.”
News
Running vs. meds for depression: Is there a clear winner?
- Author:
- Liam Davenport
Medication “generally had worse impact on body weight, heart rate variability, and blood pressure, whereas running therapy led to improved effect...
News
Exercise timing may dictate obesity, type 2 diabetes risk
- Author:
- Liam Davenport
People who exercised in the morning had a lower body mass index than those who exercised at other times, even though they were more sedentary.
News
Many patients with NSCLC receive immunotherapy ‘indefinitely’ – Are they benefiting?
- Author:
- Liam Davenport
Without “incontrovertible evidence” that immunotherapy should stop at 2 years, “many, many, many patients and clinicians are going to favor...
News
Proposed TNM update could shift staging for lung cancers
- Author:
- Liam Davenport
Lung cancers, particularly those with T1 disease, could be reclassified into a different overall stage if proposed adaptations to the N and M...
News
Osimertinib plus chemo ups PFS, toxicity in first line
- Author:
- Liam Davenport
Combining osimertinib with chemotherapy improved progression-free survival in EGFR-mutated non–small cell lung cancer, new interim data show, but...
News
Novel ADC offers hope in heavily pretreated NSCLC
- Author:
- Liam Davenport
A phase 2 trial found that almost 30% of patients receiving antibody-drug conjugate patritumab deruxtecan achieved an objective response, and...
News
Probing the link between GERD and anxiety and depression
- Author:
- Liam Davenport
An analysis suggested that a genetic risk for GERD increased the risk of developing depression or anxiety and vice versa.
News
Unlocking the secrets of brown fat
- Author:
- Liam Davenport
Since obesity results from an imbalance between energy intake and energy expenditure, one model proposes that brown adipocytes rebalance this...
News
Probiotics improve nonmotor symptoms of Parkinson’s
- Author:
- Liam Davenport
Participants taking the probiotic also saw a reduced delay in “time to on” of treatment with levodopa, thus reducing the delay until effectiveness...
News

Even an hour’s walk a week lowers risk in type 2 diabetes
- Author:
- Liam Davenport
“Our findings are particularly promising for neuropathy since, currently, no disease-modifying treatment exists, and there are limited preventive...
News
Both too much and not enough sleep raises T2D risk
- Author:
- Liam Davenport
“These findings underpin the importance of promoting healthy sleep habits to avoid sleep deprivation.”